Delivery Order SPE2DR25D2014-SPE2DR26FZ70K
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order totaling $19,186.58 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials on September 8, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The contract involves no set-aside designation, indicating open competition among...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,360.20 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This non-set-aside contract, awarded on August 21, 2025, with a completion date of August 22, 2025, represents a firm fixed-price delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $15,003.41 firm fixed-price delivery order on August 5, 2025, for the supply of Injectafer 750 mg/15 mL vials. The contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $19,856.34 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials on July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order valued at $14,143.49 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Injectafer 750 mg/15 mL vials. This firm fixed-price, non-set-aside contract is scheduled for completion by June 3, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Injectafer 750 mg/15 ml vials with a ceiling value of $16,374.43 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that enables global pharmaceutical support...
- The Defense Logistics Agency awarded a $19,061.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Injectafer 750 mg/15 mL vials. This non-set-aside contract, with a completion date of August 26, 2025, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical prime vendor vehicle with DLA, reflecting the agency's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Injectafer 750 mg/15 ml vials with a ceiling value of $13,079.20. This competitively awarded, firm fixed-price contract is classified as a child order and represents a non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order has an ultimate completion date of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of Injectafer 750 mg/15 ml vials. This is a firm fixed price delivery order with a ceiling value of $27,463.25 and an ultimate completion date of September 2, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and was awarded without a set-aside designation, indicating competitive procurement. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,075.62 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Injectafer is an intravenous iron replacement therapy used in the treatment of iron...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ70KDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,304.98 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials on November 14, 2025, with completion scheduled for November 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, with an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's federal contracting relationship with the Defense Logistics Agency reflects its established capability to meet military healthcare supply requirements through competitive procurement processes. This delivery order for Injectafer, an iron replacement therapy, supports the agency's broader objective of maintaining a reliable pharmaceutical supply chain for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 11/14/25 |